As exemplified here, understanding how tumor-intrinsic factors influence mechanisms of CD4+ T-cell activity represents an important step for leveraging the unique contributions of CD4+ and CD8+ CAR T cells for personalized medicine. The gene discussed is CD8A; the disease is neoplasm.